Department of Microbiology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, Western Australia, Australia.
School of Biomedical Sciences, Faculty of Health & Medical Sciences, The University of Western Australia, Nedlands, Western Australia, Australia.
PLoS One. 2019 Feb 8;14(2):e0201332. doi: 10.1371/journal.pone.0201332. eCollection 2019.
Bacteraemia is a risk factor for subsequent clinical deterioration and death. Current reliance on culture-based methods for detection of bacteraemia delays identification and assessment of this risk until after the optimal period for positively impacting treatment decisions has passed. Therefore, a method for rapid detection and identification of bacterial infection in the peripheral bloodstream in acutely ill patients is crucial for improved patient survival through earlier targeted antibiotic treatment. The turnaround time for current clinical laboratory methods ranges from 12 to 48 hours, emphasizing the need for a faster diagnostic test. Here we describe a novel assay for accelerated generic detection of bacteria in blood culture (BC) using peptide nucleic acid fluorescence in situ hybridization enhanced acoustic flow cytometry (PNA-FISH-AFC). For assay development, we used simulated blood cultures (BCs) spiked with one of three bacterial species at a low starting concentration of 10 CFU/mL: Escherichia coli, Klebsiella pneumoniae or Pseudomonas aeruginosa. Under current clinical settings, it takes a minimum of 12 hours incubation to reach positivity on the BacTEC system, corresponding to a bacterial concentration of 107-109 CFU/mL optimal for further analyses. In contrast, our PNA-FISH-AFC assay detected 103-104 CFU/mL bacteria in BC following a much shorter culture incubation of 5 to 10 hours. Using either PCR-based FilmArray assay or MALDI-TOF for bacterial detection, it took 7-10 and 12-24 hours of incubation, respectively, to reach the positive result. These findings indicate a potential time advantage of PNA-FISH-AFC assay for rapid bacterial detection in BC with significantly improved turnaround time over currently used laboratory techniques.
菌血症是随后临床恶化和死亡的一个风险因素。目前,基于培养的方法用于检测菌血症,这种方法会延迟对这种风险的识别和评估,直到错过积极影响治疗决策的最佳时期。因此,对于急性病患者外周血中细菌感染的快速检测和鉴定方法对于通过早期靶向抗生素治疗提高患者生存率至关重要。目前临床实验室方法的周转时间为 12 至 48 小时,这强调了对更快诊断测试的需求。在这里,我们描述了一种使用肽核酸荧光原位杂交增强声流细胞术(PNA-FISH-AFC)加速血液培养物(BC)中细菌通用检测的新型检测方法。为了进行检测开发,我们使用三种细菌(大肠杆菌、肺炎克雷伯菌或铜绿假单胞菌)的模拟血液培养物(BC)进行了研究,起始浓度为 10 CFU/mL。在当前的临床环境下,BacTEC 系统需要至少 12 小时的孵育才能达到阳性,对应于进一步分析的最佳细菌浓度为 107-109 CFU/mL。相比之下,我们的 PNA-FISH-AFC 检测方法在更短的 5 至 10 小时培养孵育后,在 BC 中检测到 103-104 CFU/mL 的细菌。使用基于 PCR 的 FilmArray 检测或 MALDI-TOF 进行细菌检测,分别需要 7-10 小时和 12-24 小时的孵育时间才能达到阳性结果。这些发现表明,与目前使用的实验室技术相比,PNA-FISH-AFC 检测方法在血液培养物中进行快速细菌检测具有潜在的时间优势,并且显著缩短了周转时间。